PEREGRINE CAPITAL MANAGEMENT LLC
Position in ARQT — Arcutis Biotherapeutics, Inc.
CIK 764529
MINNEAPOLIS, MN
Position in ARQT
as of Mar 31, 2026
· filed Apr 23, 2026
Position Value
$7,215,768
New position
Shares Held
306,272
first reported quarter
Ownership
0.245%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 37.190144707972.ToString("F0")%
Shared 0.ToString("F0")%
None 62.809855292028004.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026PEREGRINE CAPITAL MANAGEMENT LLC holds $94,824,642 across 14 Biotechnology names. ARQT ranks #5 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | XENE |
Xenon Pharmaceuticals Inc.
|
143,136 | $8,323,358 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
146,923 | $8,299,680 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
47,296 | $7,993,969 | |
| 4 | COGT |
Cogent Biosciences, Inc.
|
201,959 | $7,773,401 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
This page
|
306,272 | $7,215,768 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
146,606 | $7,207,150 | |
| 7 | CYTK |
Cytokinetics Inc
|
103,626 | $6,829,989 | |
| 8 | EWTX |
Edgewise Therapeutics, Inc.
|
208,672 | $6,573,168 |
All Filings in ARQT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,215,768 | 306,272 | Shares | Sole | 2026-04-23 | |
| No filing history on record for this holder in this stock. | ||||||